Skip to main content
SpringerLink
Log in

Procedures for microencapsulation of enzymes, cells and genetically engineered microorganisms

  • Protocol
  • Published:
Molecular Biotechnology Aims and scope Submit manuscript

Abstract

Methods to microencapsulate enzyme, cells, and genetically engineered cells have been described in this article. More specific examples of enzyme encapsulation include the microencapsulation of xanthine oxidase for Lesch-Nyhan disease; phenylalanine ammonia lyase for pheny, ketonuria and microencapsulation of multienzyme systems with cofactor recycling for multistep enzyme conversions. Methods for cell encapsulation include the details for encapsulating hepatocytes for liver failure and for gene therapy. This also includes the details of a novel two-step method for encapsulation of high concentrations of smaller cells. Another new approach is the detailed method of the encapsulation of genetically engineered Escherichia coli DH5 cells for lowering urea, ammonia, and other metabolites in kidney or, liver failure and other diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Chang, T. M. S. (1964) Semipermeable microcapsules. Science 146, 524–525.

    Article  PubMed  CAS  Google Scholar 

  2. Chang, T. M. S., MacIntosh, F. C., and Mason, S. G. (1966) Semipermeable aqueous microcapsules: I. Preparation and properties. Can. J. Physiol. Pharmacol., 44, 115–128.

    PubMed  CAS  Google Scholar 

  3. Chang, T. M. S., MacIntosh, F. C., and Mason, S. G. (1971) Encapsulated hydrophilic compositions and methods of making them. Canadian Patent, 873, 815, 1971.

    Google Scholar 

  4. Chang, T. M. S. (1972) “Artificial Cells” Monograph, Charles C Thomas Publisher, Springfield, U.S.A. 1972.

    Google Scholar 

  5. Chang, T. M. S. (1995) Artificial cells with emphasis on bioencapsulation in biotechnology. Biotechnology Annual Review 2, 267–295.

    Google Scholar 

  6. Chang, T. M. S. (1997) Recent and future developments in modified hemoglobin and microencapsulated hemoglobin as red blood cell substitutes. Artificial Cells, Blood Substitutes & Immobilization Biotechnology 25, 1–24.

    Google Scholar 

  7. Chang TMS (1997) “Blood Substitutes: principles, methods, products and clinical trials.” Karger/Landes Co. Austin, Texas.

    Google Scholar 

  8. Chang, T. M. S. and W.P. Yu (1996) Biodegradable polymer membrane containing hemoglobin for blood substitutes. U.S.A. Patent approved in 1996.

  9. Yu, W. P. and Chang, T. M. S. (1996) Submicron polymer membrane hemoglobin nanocapsules as potential blood substitutes: preparation and characterization. Artificial Cells, Blood Substitutes & Immobilization Biotechnology, an international journal 24, 169–184.

    CAS  Google Scholar 

  10. Chang, T.M.S. and Poznansky, M. J. (1968) Semipermeable microcapsules containing catalase for enzyme replacement in acatalsaemic mice. Nature 218(5138), 242–245.

    Article  Google Scholar 

  11. Chang, T. M. S. (1971) The in vivo effects of semipermeable microcapsules containing L-asparaginase on 6C3HED lymphosarcoma. Nature 229(528):117–118.

    Article  PubMed  CAS  Google Scholar 

  12. Chang, T. M. S. (1989) Preparation and characterization of xanthine oxidase immobilized by microencapsulation in artificial cells for the removal of hypoxanthine. J. Biomat., Artif. Cells. and Artif. Organs 17, 611–166.

    CAS  Google Scholar 

  13. Palmour, R. M., Goodyer, P., Reade, T., Chang, T. M. S. (1989) Microencapsulated xanthine oxidase as experimental therapy in Lesch-Nyhan Disease. Lancet 2(8664):687–688.

    Article  PubMed  CAS  Google Scholar 

  14. Chang, T. M. S., Bourget L., and Lister, C. (1992) Orgal administration of microcapsules for removal of amino acids, US Patent No 5,147,641.

  15. Chang, T. M. S., Bourget, L., and Lister, C. (1995) A new theory of enterorecirculation of amino acids and its use for depleting unwanted amino acids using oral enzyme-artificial cells, as in removing phenylalanine in phenylketonuria. Artificial Cells, Blood Substitutes & Immobilization Biotechnology, 25, 1–23.303.

    Google Scholar 

  16. Bourget, L. and Chang, T. M. S. (1986) Phenylalanine ammonia-lyase immobilized in microcapsules for the depletion of phenylalanine in plasma in phenylketonuric rat model. Biochim. Biophys. Acta. 883:432–438.

    PubMed  CAS  Google Scholar 

  17. Safos, S. and Chang, T. M. S. (1995) Enzyme replacement therapy in ENU2 phenylketonuric mice using oral microencapsulated phenylalanine ammonia-lyase: a preliminary report. Artificial Cells, Blood Substitutes & Immobilization Biotechnology, 25, 681–692.

    Google Scholar 

  18. Chang, T. M. S. (1985) Artificial cells with regenerating multienzyme systems. Methods in Enzymology 112, 195–203.

    PubMed  CAS  Google Scholar 

  19. Gu, K. F. and Chang, T. M. S. (1990) Production of essential L-branched-chained amino acids, in bioreactors containing artificial cells immobilized multienzyme systems and dextran-NAD+. Applied Biochemistry and Biotechnology 26, 263–269.

    Google Scholar 

  20. Chang, T. M. S. (1965) Semipermeable Aqueous Microcapsules. Ph.D. Thesis. McGill University.

  21. Lim, F. and Sun, A. M. (1980) Microencapsulated islets as bioartificial endocrine pancreas. Science 210, 908–909.

    Article  PubMed  CAS  Google Scholar 

  22. Wong, H. and Chang, T. M. S. (1986) Bioartificial liver: implanted artificial cells microencapsulated living hepatocytes increases survival of liver failure rats. Int. J. Artif. Organs 9, 335–336.

    PubMed  CAS  Google Scholar 

  23. Wong, H. and Chang, T. M. S. (1998) The viability and regeneration of artificial cell microencapsulated rat hepatocyte xenograft transplants in mice. J. Biomat Artif. Cells and Artif. Organs 16, 731–740.

    Google Scholar 

  24. Kashani, S. and Chang, T. M. S. (1991) Effects of hepatic stimulatory factor released from free or microencapsulated hepatocytes on galactosamine induced fulminant hepatic failure animal model. J. Biomaterials, Artificial Cells and Immobilization Biotechnology 19, 579–598.

    CAS  Google Scholar 

  25. Bruni, S. and Chang, T. M. S. (1989) Hepatocytes immobilized by microencapsulation in artificial cells: Effects on hyperbilirubinemia in Gunn Rats. J Biomat Artif Cells and Artif Organs 17, 403–412.

    CAS  Google Scholar 

  26. Bruni, S. and Chang, T. M. S. (1991) Encapsulated hepatocytes for controlling hyper-bilirubinemia in Gunn Rats. Int. J. Artificial Organs 14, 239–241.

    CAS  Google Scholar 

  27. Bruni, S. and Chang, T. M. S. (1995) Kinetics of UDP-glucuronosyl-transferase in bilirubin conjugation by encnapsulated hepatocytes for transplantation into Gunn rats J. Artificial Organs 19, 449–457.

    Article  PubMed  CAS  Google Scholar 

  28. Wong, H. and Chang T. M. S. (1991) A novel two step procedure for immobilizing living cells in microcapsules for improving xenograft survival. Biomaterials, Artificial Cells and Immobilizing Biotechnology 19, 687–698.

    CAS  Google Scholar 

  29. Chang, T. M. S. and Wong, H. (1992) A novel method for cell encapsulation in artificial cells. USA Patent No. 5,084,350.

  30. Prakash, S. and Chang, T. M. S. (1995) Preparation and in-vitro analysis of genetically engineered E. coli DH5 cells, microencapsulated in artificial cells for urea and ammonia removal. Biotechnology and Bioengineering, 46, 621–626.

    Article  CAS  PubMed  Google Scholar 

  31. Prakash, S. and Chang, T. M. S. (1996) Microencapsulated genetically engineered live E coli DH5 cells administered orally to maintain normal plasma urea level in uremic rats Nature Medicine 2, 883–887.

    Article  PubMed  CAS  Google Scholar 

  32. Friedman, E. A. (1999) Predicting nephrology in the 21st century. ASAIO J Sep–Oct;45(5):363–366.

    Article  PubMed  CAS  Google Scholar 

  33. Friedman, E. A. (1996) Bowel as a kidney substitute in renal failure. Am. J. Kidney Dis. 1996 Dec; 28(6):943–950.

    PubMed  CAS  Google Scholar 

  34. Prakash, S. and Chang, T. M. S. (1999) Artificial cell microcapsules containing genetically engineered E. coli DH5 cells for in-vitro lowering of plasma potassium, phosphate, magnesium, sodium, chloride, uric acid, cholesterol, and creatinine: a preliminary report. Artif. Cells Blood Substit. Immobil. Biotechnol. Sep–Nov;27(5–6): 475–481.

    Article  PubMed  CAS  Google Scholar 

  35. Koo, J. and Chang, T. M. S. (1993) Secretion of erythropoietin from microencapsulated rat kidney cells: preliminary results. Int. J. Artif. Organs 16, 557–560.

    PubMed  CAS  Google Scholar 

  36. Garofalo, F. and Chang, T. M. S. (1991) Effects of mass transfer and reaction kinetics on serum cholesterol depletion rates of free and immobilized Pseudomonas pictorum. Applied Biochemistry and Biotechnology 27, 75–91.

    Article  PubMed  CAS  Google Scholar 

  37. Lyold-George, I. and Chang, T. M. S. (1995) Characterization of free and alginate-polylysine-alginate microencapsulated Erwinia herbicola for the conversion of ammonia, pyruvate and phenol into L-tyrosine and L-DOPA J. Bioengineering and Biotechnology 48, 706–714.

    Article  Google Scholar 

  38. Yu, Y. T. and Chang, T. M. S. (1981) Lipid-polymer membrane artificial cells containing multienzyme systems, cofactors and substrates for the removal of ammonia and urea. Trans. Am. Soc. Artif. Intern. Organs 27, 535–538.

    PubMed  CAS  Google Scholar 

  39. Chang, T. M. S. (1971) Stabilization of enzyme by microencapsulation with a concentrated solution o or by crosslinking with glutaraldehyde. Biochem. Biophys. Res. Com. 44, 1531–1533.

    Article  PubMed  CAS  Google Scholar 

  40. Coromili, V. and Chang, T. M. S. (1993) Polydisperse dextran as a diffusing test solute to study the membrane permeability of alginate polylysine microcapsules. J. Biomaterials, Artificial Cells & Immobilization Biotechnology, 21, 323–335.

    Google Scholar 

  41. Chang, T. M. S. and Prakash, S. (1998) Therapeutic uses of microencapsulated genetically engineered cells. Molecular Medicine Today May; 4(5):221–227.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Artificial Cells & Organs Research Centre, McGill University, 3655 Drummond Street, Room 1005, H3G 1Y6, Montreal, Quebec, Canada

    T. M. S. Chang

Authors
  1. T. M. S. Chang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Prakash
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chang, T.M.S., Prakash, S. Procedures for microencapsulation of enzymes, cells and genetically engineered microorganisms. Mol Biotechnol 17, 249–260 (2001). https://doi.org/10.1385/MB:17:3:249

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1385/MB:17:3:249

Index Entries

Search

Navigation